Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ZafGen
Biotech
Levo Therapeutics’ Prader-Willi med fizzles in phase 3
Levo Therapeutics’ lead program did not beat placebo in a phase 3 study of Prader-Willi syndrome, a genetic disorder that causes insatiable hunger.
Amirah Al Idrus
Aug 6, 2020 9:44pm
Zafgen hangs 'for sale' sign as chances of recovery fade
Sep 5, 2019 11:52am
Zafgen nabs ex-Biogen executive Priya Singhal as new R&D chief
Mar 4, 2019 11:05am
FDA hits Zafgen’s beloranib successor with clinical hold
Nov 26, 2018 9:00am
Chutes & Ladders—CAR-T player Cellectis poaches Novartis exec
Aug 10, 2018 9:00am
Thomas Hughes leaves Zafgen to take CEO role at Navitor
Aug 3, 2018 9:00am
